The counter-intuitive consequence: AI ad copy for a Malaysian clinic remains fully governed by the existing KKM/MDC advertising rules, with no AI carve-out and no dilution.
This post exists because the assumption "AI ad copy will be regulated differently" is intuitive and wrong. Under Malaysia's AI Governance Bill as consulted on in July 2026, it will not be. The rules that already govern clinic advertising are the rules that will govern your AI-drafted clinic advertising.
The 24 June 2026 statement
In a Parliamentary reply on 24 June 2026, Digital Minister Gobind Singh Deo confirmed the AI Governance Bill would not regulate AI-generated content directly. The Bill's scope is the deployment of AI systems, not the content those systems produce.
That distinction matters because it closes off an argument some vendors have been making — that AI-drafted copy is somehow governed by a new, softer regime.
Which rules actually apply
Every rule that applied to human-drafted clinic ad copy on 23 June 2026 still applies on 25 June 2026 and will still apply after the Bill passes:
- KKM Guidelines on Aesthetic Medical Practice — including the LCP (Letter of Credentialing and Privileging) requirement for the 12 specified aesthetic procedures.
- PHFSA 1998 — premise registration and premise-advertising rules for private healthcare facilities.
- Medicines Act 1956 — restrictions on advertising of controlled and prescription products.
- Medicine Advertisement Board (MAB / LIU) pre-approval for any advertisement of medicinal products.
- Malaysian Medical Council (MDC) Code of Professional Conduct — advertising provisions.
- Platform-specific health-content policies — Google, Meta, TikTok and XHS each carry independent restrictions that operate on top of the statutory ones.
None of the above have an AI carve-out. None of them will have one after the Bill passes.
Where AI-generated copy most often trips
Six failure modes we see repeatedly when clinics adopt AI copy tools without a compliance review step:
- Guaranteed outcomes. LLMs default to confident language. "Guaranteed results", "permanent", "risk-free" — all restricted under KKM guidance.
- Before/after imagery paired with AI captions. The imagery is the primary restriction; the AI caption around it does not launder it.
- Comparative superiority claims. "Better than", "safer than", "the leading". MDC restricts comparative advertising.
- Price-led promotion. "50% off", "starting from RM199". Price-led aesthetic-service promotion is restricted under KKM guidance.
- Unverified credentials. LLMs will confidently invent qualifications. Every credentialing claim in an AI-drafted ad must be verified against actual practitioner records.
- Testimonial framing. AI-synthesised testimonial-style copy that is not attributable to a real, consenting patient is a two-way problem — MDC advertising rules and PDPA consent.
The one-step review that catches most of this
Run every AI-drafted clinic ad through the KKM Ad Checker before publish. It is designed exactly for this workflow — the tool does not care whether a human or an LLM wrote the copy; it checks the copy against the applicable KKM/MDC restrictions.
What this means for clinic marketing operations
Two operating principles:
- AI drafts, human approves. The human approval step is the compliance gate. This is also the Deployer "human oversight" obligation under Tier 2 of the AI Bill, so the same step serves both regimes.
- Every AI-drafted asset gets a compliance annotation before publish. Which rule was checked, by whom, on what date. This is not paperwork for its own sake — it is what a PHFSA audit looks at.
Related reading
References
- Hansard, Parliamentary reply by Minister Gobind Singh Deo, 24 June 2026
- KKM Guidelines on Aesthetic Medical Practice (current issue)
- Private Healthcare Facilities and Services Act 1998 (PHFSA)
- Malaysian Medical Council Code of Professional Conduct — advertising provisions
- Medicines Act 1956; Medicine Advertisement Board (MAB) requirements
Ready to grow your business with proven digital marketing?
Our team specialises in performance marketing for Malaysian businesses — from clinics and property developers to national institutions and marketplace brands.
Published by shakalakaa team · Editorial standards